top of page
vecteezy_abstract-geometric-background-of-fluid-liquid-and-dynamic_21304287_edited_edited_
tta sweden logga med text.png

a VINNOVA-funded innovation initiative

NEWS

Theranostics Trial Alliance Sweden, TTA Sweden: National Strategy – Positioning Sweden at the Forefront of Radiotheranostics Clinical Research

     06-11-2026, 12.15 – 16.15
     H1 Röd Room, Alfred Nobels allé 23, 141 52 Huddinge,         
      Sweden

Target audience 
Researchers, clinicians, healthcare leaders, policymakers, regulatory authorities, life science companies, patient representatives and other stakeholders involved in radiopharmaceutical development and clinical trials.

 

Purpose

The TTA Sweden Annual Symposium will explore how Sweden comes together to strengthen its capacity to conduct clinical trials with radiopharmaceuticals and become a more attractive partner for national and international study sponsors.

 

The symposium will bring together leading national and international experts in onco-theranostics and will highlight new developments, opportunities and practical solutions for expanding clinical-trial capacity, strengthening national coordination, accelerating radiopharmaceutical manufacturing and study start-up, improving patient recruitment, and facilitating multicentre trials. It will also showcase current initiatives and capabilities within TTA Sweden.

 

See the program below.

 

The symposium is free of charge. Register to secure your attendance.



 

Preliminary Symposium Program

 

12.00 – 12.30    Coffee and registration

 

12.30 – 12.35    Welcome by Prof Fredrik Frejd and Associate prof Thuy Tran

 

12.35 – 13.05    Invited keynote speaker Prof Willemien Menke-van der Houven van Oort, Amsterdam UMC

                          PET imaging in oncology for drug development and as a tool for patient selection and treatment                                            evaluation

 

13.05 – 13.15    Dr. Sara Strandberg, PhD, Associate prof, Umeå University Hosptial, Umeå University

                          Title: TBD

 

13.15 – 13.45    Coffee break

 

13.45 – 13.55    Prof Mark Lubberink, Uppsala University

                          Title: TBD

 

14.00 – 14.30    Keynote speaker to be confirmed

 

14.30 – 15.00    Panel discussion: Sponsor perspectives on accelerating radiopharmaceutical clinical development

                          Key stakeholders and priorities

 

15.00 – 15.15    Short break

 

15.15 – 15.45    Tribute session honouring Professor Rimma Axelsson

                          Chair: prof Håkan Geijer

 

15.50 – 16.00    Closing remarks

                          Prof Rimma Axelsson

Study protocol article Her2-Ex PET trial published in Frontiers in Oncology, April 10, 2026.

Read the full article here

Screenshot 2026-04-28 at 13.40.27.png

Webbinar: health economics May 4, 2026

The webinar will be held in Swedish and will take place via Teams from 15:00-16.30.
Teams link: 
https://teams.microsoft.com/meet/34046749700331?p=wkZOKEMYLypcSIWDRY

Mötes-ID: 340 467 497 003 31

Lösenord: JM9sH6Dd

Screenshot 2026-02-25 at 09.57.24.png
bottom of page